Results 251 to 260 of about 9,352,293 (347)

Erratum for: Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. [PDF]

Radiology
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG, Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium.   +29 more
europepmc   +1 more source

Infliximab for the treatment of fistulas in patients with Crohn's disease.

New England Journal of Medicine, 1999
Tephan, Argan, tephen, H. B., Anauer, A. R, van, Ogezand, Aniel, P. K., Odolsky, Anja, Raakman, Homas, S. F., Chaible, Ander, H. J., Eventer   +18 more
semanticscholar   +1 more source

A Population‐Based Matched Cohort Study of Extra‐Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy, Faria Ahmed, Michael Pugliese, Monica Taljaard, Parul Tandon, Priscilla Matthews, Gilaad G. Kaplan, Stephanie Coward, Charles N. Bernstein, Eric I. Benchimol, M. Ellen Kuenzig, Laura E. Targownik, Harminder Singh, on behalf of the Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC)   +13 more
wiley   +1 more source

Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease. [PDF]

Sci Rep
Dotlacil V, Coufal S, Lerchova T, Zarubova K, Kucerova B, Tlaskalova-Hogenova H, Kverka M, Skaba R, Bronsky J, Hradsky O, Rygl M.   +10 more
europepmc   +1 more source

Updating predictors of endoscopic recurrence after ileocolic resection for Crohn disease

, 2017
Sara Monteiro, Tiago Cúrdia Gonçalves, Pedro Boal Carvalho, Maria João Moreira, José Cotter   +4 more
openalex   +2 more sources

Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach

Gut, 2005
C. Manichanh, L. Rigottier-Gois, Elian Bonnaud, K. Gloux, É. Pelletier, L. Frangeul, R. Nalin, C. Jarrin, P. Chardon, P. Marteau, Joaquim Roca, J. Doré   +11 more
semanticscholar   +1 more source

Intestinal Ultrasound Transmural Healing Was Associated With Improved Long‐Term Outcomes Among Patients With Endoscopic Remission: Results of a Prospective Study

Alimentary Pharmacology &Therapeutics, EarlyView.
This a prospective study showing the benefit of intestinal ultrasound transmural healing on long term outcome among patient with partial and complete endoscopic healing in Crohn's disease. ABSTRACT Background STRIDE II guidelines recognise endoscopic healing as a main therapeutic target in Crohn's disease (CD).
Clara Yzet, Amélie Plancke, Franck Brazier, Lucien Grados, Elise Derval, Louise Ghilardi, Momar Diouf, Adrien Ollier, Mathurin Fumery   +8 more
wiley   +1 more source

Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. [PDF]

Radiology
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG, Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium.   +29 more
europepmc   +1 more source

Meckel diverticulum involved in Crohn disease

, 2018
Henry Knipe
openalex   +1 more source

Serum Villin‐1—A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation

Alimentary Pharmacology &Therapeutics, EarlyView.
Serum villin‐1 is a non‐invasive indicator of gut barrier damage and short‐term mortality in acutely decompensated cirrhosis. Incorporating villin‐1 assessment into risk stratification methods improves prognostic accuracy by capturing an essential, yet previously overlooked component of disease progression.
David Tornai, Boglarka Balogh, Aniko Csillag, Andras Budai, Andras Kiss, Peter Antal‐Szalmas, Gabor Mehes, Lukacs Barath, Tamas Tornai, Istvan Tornai, Zsuzsanna Vitalis, Nora Sipeki, Tamas Dinya, Attila Enyedi, Florian A. Rosenberger, Wim Laleman, Minneke J. Coenraad, Ferran Aguilar, Joan Claria, Richard Moreau, Jonel Trebicka, Maria Papp, on behalf of MICROB‐PREDICT and PREDICT study group of the EASL‐CLIF consortium   +22 more
wiley   +1 more source